| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |